`
`Glaucoma Treatments - Print Article - MPR
`
`October 13, 2017
`
`Glaucoma Treatments
`
` Download: Glaucoma Treatments
`
`Brand
`
`GLAUCOMA TREATMENTS
`Strength
`Size
`Form
`
`Adult Dose
`
`Generic
`ALPHA2-AGONISTS
`apraclonidine HCl
`
`Iopidine
`
`5mL, 10mL
`
`soln1
`
`0.5%
`5mL, 10mL
`soln1
`brimonidine tartrate Alphagan P
`0.1%, 0.15% 5mL, 10mL, 15mL soln2
`ALPHA2-AGONIST + BETA-BLOCKER
`Combigan
`brimonidine tartrate/
`0.2%/0.5%
`timolol maleate
`BETA-BLOCKERS
`betaxolol HCl
`
`1–2 drops 3 times daily
`
`1 drop every 8hrs
`
`1 drop every 12hrs
`
`1–2 drops twice daily
`
`1–2 drops twice daily
`
`1 drop twice daily
`
`1–2 drops once or twice daily
`
`1 drop twice daily
`
`1 drop twice daily
`
`1 drop once daily in the
`morning
`Initially 1 drop of 0.25% twice
`daily; max 1 drop of 0.5%
`twice daily
`
`1 drop once daily
`
`500mg twice daily
`
`1 drop 3 times daily
`
`1 drop 3 times daily
`
`50–100mg twice to three times
`daily
`
`—
`
`Betoptic S
`
`carteolol HCl
`
`—
`
`levobunolol HCl
`
`Betagan
`
`metipranolol HCl
`
`Optipranolol
`
`timolol hemihydrate Betimol
`
`timolol maleate
`
`Istalol
`
`0.5%
`
`0.25%
`
`1%
`
`0.5%
`
`5mL, 10mL, 15mL soln1
`2.5mL, 5mL,
`susp1
`10mL, 15mL
`5mL, 10mL, 15mL soln1
`5mL, 10mL, 15mL soln1
`0.3%
`5mL, 10mL
`soln1
`0.25%, 0.5% 5mL, 10mL, 15mL soln1
`0.5%
`5mL
`soln1
`
`—
`
`0.25%, 0.5% 5mL, 10mL
`
`Timoptic
`Ocudose
`Timoptic-XE
`
`0.25%, 0.5% 60
`
`0.25%, 0.5% 2.5mL, 5mL
`
`CARBONIC ANHYDRASE INHIBITORS
`Diamox
`acetazolamide
`500mg
`Sequels
`Azopt
`
`brinzolamide
`
`1%
`
`dorzolamide HCl
`
`Trusopt
`
`2%
`
`100
`
`2.5mL, 5mL,
`10mL, 15mL
`10mL
`
`methazolamide
`
`Neptazane
`
`25mg, 50mg
`
`90
`
`soln1
`soln4
`
`gel-
`forming
`soln
`
`sust-rel
`caps
`susp1
`
`soln1
`tabs
`
`NOTES
`Key: soln = solution; sust-rel caps = sustained release capsules; susp = suspension
`Exhibit 1057
`1Contains benzalkonium chloride. May be absorbed by soft contact lenses.
`2Contains purite.
`ARGENTUM
`3Contains sofZia (boric acid, propylene glycol, sorbitol, zinc chloride).
`IPR2017-01053
`4Preservative-free.
`Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact
`company for full drug labeling.
`
`(Rev. 8/2017)
`
`https://www.empr.com/glaucoma-treatments/printarticle/180363/
`
`1/2
`
`000001
`
`
`
`Glaucoma Treatments - Print Article - MPR
`GLAUCOMA TREATMENTS
`Strength
`Size
`Form
`Brand
`Generic
`CARBONIC ANHYDRASE INHIBITOR + ALPHA-AGONIST
`Simbrinza
`brinzolamide/
`1%/0.2%
`8mL
`brimonidine tartrate
`CARBONIC ANHYDRASE INHIBITOR + BETA-BLOCKER
`Cosopt
`2%/0.5%
`10mL
`dorzolamide HCl/
`timolol maleate
`
`4/24/2018
`
`Cosopt PF
`
`2%/0.5%
`
`0.2mL
`
`CHOLINERGIC (MIOTIC) AGONISTS
`Isopto
`15mL
`carbachol
`1.5%
`Carbachol
`15mL, 30mL
`3%
`1%, 2%, 4% 15mL
`
`pilocarpine HCl
`
`Isopto
`Carpine
`
`Pilopine HS
`
`4%
`
`4g
`
`CHOLINESTERASE INHIBITORS
`ecothiophate iodide Phospholine
`Iodide
`
`0.03%, 0.06%,
`0.125%,
`0.25%
`
`5mL
`
`PROSTAGLANDIN ANALOGS
`Lumigan
`bimatoprost
`
`latanoprost
`
`Xalatan
`
`0.01%, 0.03% 2.5mL, 5mL,
`7.5mL
`2.5mL
`
`0.005%
`
`tafluprost
`
`travoprost
`
`Zioptan
`
`0.0015%
`
`0.3mL
`
`Travatan Z
`
`0.004%
`
`2.5mL, 5mL
`
`Adult Dose
`
`1 drop three times daily
`
`1 drop twice daily
`
`2 drops up to 3 times daily
`
`2 drops up to 3–4 times daily
`or more if needed. Heavily
`pigmented irides: need higher
`concentrations.
`Apply ½ inch ribbon in lower
`conjunctival sac at bedtime
`
`0.03% soln instilled twice daily.
`If being transferred due to
`unsatisfactory control with
`pilocarpine, carbachol,
`epinephrine, etc, use higher
`strength soln.
`
`1 drop once daily in the
`evening
`1 drop once daily in the
`evening
`1 drop once daily in the
`evening
`1 drop once daily in the
`evening
`
`1 drop twice daily
`
`susp1
`
`soln1
`soln4
`
`soln1
`
`soln1
`
`gel1
`
`soln
`
`soln1
`
`soln1
`
`soln4
`
`soln3
`
`soln1
`
`PROSTANOIDS (DOCOSANOIDS)
`Rescula
`unoprostone
`isopropyl
`SYMPATHOMIMETICS
`Propine
`dipivefrin HCl
`
`0.15%
`
`5mL
`
`0.1%
`
`5mL, 10mL, 15mL soln1
`
`1 drop every 12hrs
`
`NOTES
`Key: soln = solution; sust-rel caps = sustained release capsules; susp = suspension
`1Contains benzalkonium chloride. May be absorbed by soft contact lenses.
`2Contains purite.
`3Contains sofZia (boric acid, propylene glycol, sorbitol, zinc chloride).
`4Preservative-free.
`Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact
`company for full drug labeling.
`
`(Rev. 8/2017)
`
`This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
`Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions
`
`https://www.empr.com/glaucoma-treatments/printarticle/180363/
`
`2/2
`
`000002
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
